Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma.
Mengxuan ZuoYuzhe CaoYi YangGuanglei ZhengDa LiHongyan ShaoQiaoyun MaPeng SongChao AnWang LiPublished in: Hepatology international (2024)
The study has been retrospectively registered at Chinese Clinical Trial Registry ( https://www.chictr.org.cn/ , ChiCTR2300075828).